Millennium Management’s ACELYRIN SLRN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-149,298
Closed -$369K 6294
2025
Q1
$369K Sell
149,298
-4,565,104
-97% -$10.9M ﹤0.01% 4991
2024
Q4
$14.8M Sell
4,714,402
-772,770
-14% -$3.74M 0.01% 1788
2024
Q3
$27.1M Buy
5,487,172
+845,116
+18% +$4.36M 0.01% 1290
2024
Q2
$20.5M Buy
4,642,056
+628,528
+16% +$2.95M 0.01% 1484
2024
Q1
$27.1M Buy
+4,013,528
New +$30.5M 0.01% 1280
2023
Q3
Sell
-732,020
Closed -$15.5M 6521
2023
Q2
$15.3M Buy
+732,020
New +$15M 0.01% 1637

Other funds holding SLRN

Millennium Management's SLRN Position: Q2 2025 in Review

Millennium Management sold out of ACELYRIN (SLRN) in Q2 2025, closing a stake of 149,298 shares — an estimated $369K sold.

Millennium Management first reported a position in SLRN in Q2 2023 and held it in 6 quarters. The position peaked at $27.1M in Q1 2024. 2 funds tracked by Wall St. Rank hold SLRN as of Q2 2025.

  • Millennium Management reported no remaining ACELYRIN position as of Q2 2025 after selling out during the quarter.
  • Millennium Management sold 149,298 ACELYRIN shares in Q2 2025, an estimated $369K.
  • Millennium Management first reported a position in ACELYRIN in Q2 2023 and held it in 6 quarters.
  • Millennium Management's ACELYRIN position peaked at $27.1M in Q1 2024.
  • 2 funds tracked by Wall St. Rank held ACELYRIN as of Q2 2025.

Based on Millennium Management's 13F filing for Q2 2025, filed 14 Aug 2025.